Mural Oncology is discontinuing the development of nemvaleukin alfa in ovarian cancer after a Phase III trial failed to improve overall survival (OS) in platinum-resistant ovarian cancer (PROC ...

Imunon has announced the alignment of the US Food and Drug Administration (FDA) with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol. IMNN-001, the company’s lead candidate ...

In patients with nonobstructive hypertrophic cardiomyopathy (nHCM) treatment with a cardiac myosin inhibitor does not seem to yield significant improvements in quality-of-life (QoL) or oxygen ...

Health Canada’s approval enables 4Moving Biotech to initiate the INFLAM MOTION Phase 2a clinical trial The INFLAM MOTION trial serves as a proof-of-concept study for 4Moving Biotech’s flagship ...

Lilly is conducting Phase III trials of the drug for weight management in adults with obesity or overweight with at least one weight-related medical problem, for which data is expected to be ...

The INFLAM MOTION Study is a Phase 2a multicenter, randomized, double-blind, placebo-controlled trial conducted in the EU, US, and Canada, including three sites in Canada. It will enroll 129 ...

From muscle to luxury, GM had it covered. But this dominance came with internal politics and fear of brand competition. Some ...

The No. 36 Corvette Z06 GT3.R is in a class of its own. Tag-teamed by Corvette factory driver Tommy Milner and paraplegic driver Robert Wickens, the No. 36 Corvette Racing machine features hand ...

Hand-control braking system from Bosch to be utilized for first time in GTD (Grand Touring Daytona) class at Long Beach Wickens moves from IMSA TCR (Touring Car class) to GTD class with Corvette ...

Once we can find the current equity value of the brand, the next step would be to run brand-positioning workshops. Phase III—Developing the Brand Positioning Platforms: Where Can We Take It Tomorrow ...